Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 14/20 | 0.43 |
| ▸ | PTGS1 | P23219 | 7/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | AURKA | O14965 | 1/20 | 0.38 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.38 |
| ▸ | KDR | P35968 | 1/20 | 0.38 |
| ▸ | AURKB | Q96GD4 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8188096 | 0.94 | PTGS2 (0.42) | PTGS2PTGS1MEN1KMT2AAURKA | |
| SCHEMBL8196687 | 0.90 | PTGS2 (0.41) | PTGS2PTGS1ALDH1A1LMNARAB9A | |
| SCHEMBL8196703 | 0.88 | PTGS2 (0.42) | PTGS2PTGS1KMT2AALDH1A1LMNA | |
| SCHEMBL8196005 | 0.87 | MEN1 (0.39) | PTGS2PTGS1MEN1KMT2AAURKA | |
| SCHEMBL8199737 | 0.86 | PTGS2 (0.40) | PTGS2PTGS1ALDH1A1LMNA | |
| SCHEMBL8196014 | 0.86 | ALDH1A1 (0.37) | PTGS2AURKANTRK1KDRAURKB | |
| SCHEMBL8188126 | 0.85 | MEN1 (0.40) | PTGS2PTGS1MEN1KMT2AAURKA | |
| SCHEMBL8058037 | 0.85 | PTGS2 (0.57) | PTGS2PTGS1 | |
| SCHEMBL8197292 | 0.84 | PTGS2 (0.40) | PTGS2PTGS1ALDH1A1 | |
| SCHEMBL8194835 | 0.82 | PTGS2 (0.41) | PTGS2PTGS1ALDH1A1LMNARAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2000018741-A2 | PYRAZOLE COMPOUNDS AS COX-2 INHIBITORS | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 2000-04-06 | — | — | WO | claimed |